Advent Pharma Ltd. reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was BDT 145.13 million compared to BDT 126.01 million a year ago. Net income was BDT 27.45 million compared to BDT 20.79 million a year ago. Basic earnings per share from continuing operations was BDT 0.29 compared to BDT 0.22 a year ago.
For the nine months, sales was BDT 410.64 million compared to BDT 387.93 million a year ago. Net income was BDT 89.88 million compared to BDT 93.26 million a year ago. Basic earnings per share from continuing operations was BDT 0.97 compared to BDT 1 a year ago.